{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:08:53Z","timestamp":1763755733039,"version":"3.45.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.dmd.2025.100182","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T17:18:23Z","timestamp":1762535903000},"page":"100182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Total drug\u2019s last stand on phospholipidosis: Unbound drug rules!"],"prefix":"10.1016","volume":"53","author":[{"given":"Dennis A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8287-6878","authenticated-orcid":false,"given":"Cornelis E.C.A.","family":"Hop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.dmd.2025.100182_bib1","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1021\/acs.jmedchem.5c00725","article-title":"Free drug concepts: a lingering problem in drug discovery","volume":"68","author":"Webborn","year":"2025","journal-title":"J Med Chem"},{"issue":"23","key":"10.1016\/j.dmd.2025.100182_bib2","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett"},{"issue":"15","key":"10.1016\/j.dmd.2025.100182_bib3","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1021\/acs.jmedchem.5b00201","article-title":"Volume of distribution in drug design: miniperspective","volume":"58","author":"Smith","year":"2015","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.dmd.2025.100182_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/dmd.118.085951","article-title":"Intracellular and intraorgan concentrations of small molecule drugs: theory, uncertainties in infectious diseases and oncology, and promise","volume":"47","author":"Smith","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmd.2025.100182_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0026-895X(25)09636-1","article-title":"Comparison of location and binding for the positively charged 1, 4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes","volume":"36","author":"Mason","year":"1989","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100182_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/taap.1999.8632","article-title":"Interactions of macrolide antibiotics (erythromycin A, roxithromycin, erythromycylamine [dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models","volume":"156","author":"Montenez","year":"1999","journal-title":"Toxic Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100182_bib7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/tx9003825","article-title":"Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds","volume":"23","author":"Hanumegowda","year":"2010","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100182_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/hsz-2019-0270","article-title":"Emerging mechanisms of drug-induced phospholipidosis","volume":"401","author":"Breiden","year":"2019","journal-title":"Biol Chem"},{"issue":"12","key":"10.1016\/j.dmd.2025.100182_bib9","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1021\/acs.molpharmaceut.7b00480","article-title":"Quantitative assessment of drug delivery to tissues and association with phospholipidosis: a case study with two structurally related diamines in development","volume":"14","author":"Loryan","year":"2017","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.dmd.2025.100182_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11095-004-1885-8","article-title":"Interaction of the macrolide antibiotic azithromycin with lipid bilayers: effect on membrane organization, fluidity, and permeability","volume":"22","author":"Berquand","year":"2005","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.dmd.2025.100182_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2012.10.026","article-title":"Pharmacokinetic drivers of toxicity for basic molecules: strategy to lower pKa results in decreased tissue exposure and toxicity for a small molecule Met inhibitor","volume":"266","author":"Diaz","year":"2013","journal-title":"Toxic Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100182_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrd.2018.26","article-title":"Impact of target interactions on small-molecule drug disposition: an overlooked area","volume":"17","author":"Van Waterschoot","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.dmd.2025.100182_bib13","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.drudis.2018.06.010","article-title":"Importance of target-mediated drug disposition for small molecules","volume":"23","author":"Smith","year":"2018","journal-title":"Drug Discov Today"},{"issue":"10","key":"10.1016\/j.dmd.2025.100182_bib14","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1124\/dmd.111.040253","article-title":"Measurement of binding of basic drugs to acidic phospholipids using surface plasmon resonance and incorporation of the data into mechanistic tissue composition equations to predict steady-state volume of distribution","volume":"39","author":"Small","year":"2011","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625094917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625094917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:56:39Z","timestamp":1763754999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625094917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0090955625094917"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100182","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total drug\u2019s last stand on phospholipidosis: Unbound drug rules!","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100182"}}